Can rectal cancer patients survive even if they take targeted drugs?

Whether rectal cancer patients can survive with targeted drug treatment varies from person to person. If they are sensitive to the drugs, their survival period is expected to be more than 10 years. However, if the effect is not good and the disease progresses rapidly, they may die after only 3 to 6 months of medication.

Before using targeted drugs, genetic testing is required. If sensitive mutations are found, the corresponding targeted drugs will be given, which have better treatment effects and fewer side effects. Some people follow the doctor's advice to use targeted drugs correctly and promptly in the early stages of the disease, and are more sensitive to the drugs. The treatment effect is better, the disease is quickly controlled, and the survival period is longer, hopefully up to 10 years, or even longer.

Some people are already in the late stage of rectal cancer when it is discovered, and due to their physical constitution, they are insensitive to targeted drugs, and the effects are poor after using them. The disease progresses rapidly. Therefore, it is possible that the disease worsens and death occurs after only 3 to 6 months of drug treatment.

If you experience symptoms such as bloody stools, lower abdominal distension, pain, etc., you should go to a regular medical institution as soon as possible, seek treatment as soon as possible after a clear diagnosis, and try to prolong your survival time.